|Non-ECA Members:||EUR 199,--|
|ECA Members:||EUR 149,--|
(All prices excl. VAT)
If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: email@example.com
The topic “data integrity” is at present one of the major focal points in national and international Health Authority inspections. The American FDA has found a significant number of deviations which were reported in warning letters in the last years. In addition to the assurance of product quality the authorities require from all companies a clear strategy how the integrity of critical data can be ensured over their entire lifecycle. The Review of Audit Trails plays a key role in this respect. Despite the various guidelines which were published after 2015 there is no clarity about the requirements for Audit Trail review and how it can be implemented in the daily business.
The Webinar aims to focus on the critical elements of data integrity and Audit Trail Review:
Regulatory Overview with emphasis on the requirements of MHRA and Annex 11
Classification of data – which are critical data?
Classification of systems – which systems are relevant?
What Audit Trails are of importance?
What shall I do with legacy systems without Audit Trail?
Who shall review Audit Trails?
How is it documented?
What process and documentation is appropriate in case of deviations?
The audience of this Webinar should be collaborators from QC, QA, production and IT, which are dealing with data integrity and the review of Audit Trails, are engaged as system administrators or manage computer systems in the GMP area.
Dr Wolfgang Schumacher worked for ASTA Medica and F. Hoffmann-La Roche and has more than 30 years of experience in the Pharmaceutical Industry. After a successful career in Cancer Research he focused on the management of national and FDA inspections, auditing of contract manufacturers and the accountability as QP. At Roche he established the IT quality assurance department and was recently accountable in Technical Operations as Vice Director for the GMP/CSV compliance of all global computer systems and the setup of the Data Integrity program, for Genentech as well.